Gedeon Richter RGEDF Stock
Gedeon Richter Price Chart
Gedeon Richter RGEDF Financial and Trading Overview
| Gedeon Richter stock price | 40.7 USD |
| Previous Close | 41.16 USD |
| Open | 37.45 USD |
| Bid | 40.04 USD x 20000 |
| Ask | 41.81 USD x 10000 |
| Day's Range | 37.45 - 37.45 USD |
| 52 Week Range | 29.23 - 45.28 USD |
| Volume | 100 USD |
| Avg. Volume | 553 USD |
| Market Cap | 7.42B USD |
| Beta (5Y Monthly) | 0.31 |
| PE Ratio (TTM) | 11.306584 |
| EPS (TTM) | 3.6 USD |
| Forward Dividend & Yield | 2.11 (5.17%) |
| Ex-Dividend Date | June 3, 2026 |
| 1y Target Est | N/A |
RGEDF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | 11.306584 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.0055898055 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Gedeon Richter Stock Price History
| Beta (5Y Monthly) | 0.31 |
| 52-Week Change | 31.64% |
| S&P500 52-Week Change | 13.32% |
| 52 Week High | 45.28 USD |
| 52 Week Low | 29.23 USD |
| 50-Day Moving Average | 39.55 USD |
| 200-Day Moving Average | 38.2 USD |
RGEDF Share Statistics
| Avg. Volume (3 month) | 553 USD |
| Avg. Daily Volume (10-Days) | 1.55K USD |
| Shares Outstanding | 182.39M |
| Float | 183.05M |
| Short Ratio | N/A |
| % Held by Insiders | 25.24% |
| % Held by Institutions | 39.35% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 407.00% |
| Payout Ratio | 0.555 |
| Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 25.82% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 67.77% |
| EBITDA Margin | 40.31% |
Management Effectiveness
| Return on Assets (ttm) | 11.97% |
| Return on Equity (ttm) | 17.56% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 9.09% |
| Gross Profit (ttm) | N/A |
| EBITDA | 380.8B USD |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 3.6 |
| Quarterly Earnings Growth (yoy) | 64.70% |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 6.65 USD |
| Current Ratio (mrq) | 4.192 |
| Book Value Per Share (mrq) | 7281.774 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | 202.27B USD |
Profile of Gedeon Richter
| Country | United States |
| State | N/A |
| City | Budapest |
| Address | Gyömroi út 19-21 |
| ZIP | 1103 |
| Phone | 36 1 431 4000 |
| Website | https://www.gedeonrichter.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 11155 |
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, it produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, which are emergency contraceptive pills; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound healing; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergies; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; and Oralsept, a sore throat and local anesthetic. Further, it engages in the provision of financial accounting, social and welfare, portfolio management, catering, carriage transportation, engineering, asset management, and biotechnological manufacturing and research services; pharmaceutical retail; trading of biotech products; and sale of medical equipment. It has strategic co-development and license agreement with Adalvo Ltd. for a proposed bioequivalent to Semaglutide injection, a GLP-1 receptor agonist indicated for chronic weight management. Additionally, it has a strategic research collaboration with FimmCyte AG for the development of first-in-class antibody, FMC2', for the treatment of endometriosis. The company was founded in 1901 and is headquartered in Budapest, Hungary.
Q&A For Gedeon Richter Stock
What is a current RGEDF stock price?
Gedeon Richter RGEDF stock price today per share is 40.7 USD.
How to purchase Gedeon Richter stock?
You can buy RGEDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Gedeon Richter?
The stock symbol or ticker of Gedeon Richter is RGEDF.
Which industry does the Gedeon Richter company belong to?
The Gedeon Richter industry is Drug Manufacturers - Specialty & Generic.
How many shares does Gedeon Richter have in circulation?
The max supply of Gedeon Richter shares is 182.39M.
What is Gedeon Richter Price to Earnings Ratio (PE Ratio)?
Gedeon Richter PE Ratio is 11.30658400 now.
What was Gedeon Richter earnings per share over the trailing 12 months (TTM)?
Gedeon Richter EPS is 3.6 USD over the trailing 12 months.
Which sector does the Gedeon Richter company belong to?
The Gedeon Richter sector is Healthcare.
